Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$6.81M$6.81Mderived+31.6% vs Q4 2022 Net Income-$4.62M-$4.62MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$4,013,000+19.2% Operating Incomederived-$4,706,000N/M Operating Cash Flowderived-$1,169,000N/M Free Cash Flowderived-$1,190,000N/M Margins · derivedGross margin58.9%−6.1 pt vs Q4 2022
Operating margin-69.1%+17.3 pt vs Q4 2022
Net margin-67.8%+16.9 pt vs Q4 2022
ended Dec 31, 2023 · filed Mar 12, 2024 · 72 d after period end